EIB is providing up to €37.5 million in venture debt to Xeltis as part of a new €50 million financing package that will help bring aXess, the company’s regenerative vascular access conduit, to market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback